David Altshuler - Aug 8, 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
EVP, Global Research and CSO
Signature
/s/ Joy Liu, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Aug 8, 2022
Transactions value $
-$136,930
Form type
4
Date filed
8/10/2022, 04:06 PM
Previous filing
Jul 21, 2022
Next filing
Nov 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Options Exercise $245K +1.3K +3.61% $187.53 37.4K Aug 8, 2022 Direct
transaction VRTX Common Stock Sale -$64.5K -222 -0.59% $290.32 37.2K Aug 8, 2022 Direct F1, F2, F3
transaction VRTX Common Stock Sale -$124K -424 -1.14% $291.53 36.7K Aug 8, 2022 Direct F1, F2, F4
transaction VRTX Common Stock Sale -$61.5K -210 -0.57% $293.02 36.5K Aug 8, 2022 Direct F1, F2, F5
transaction VRTX Common Stock Sale -$88.8K -302 -0.83% $293.99 36.2K Aug 8, 2022 Direct F1, F2, F6
transaction VRTX Common Stock Sale -$43.1K -146 -0.4% $295.14 36.1K Aug 8, 2022 Direct F1, F2, F7

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction VRTX Stock Option (Right to Buy) Options Exercise $0 -1.3K -33.34% $0.00 2.61K Aug 8, 2022 Common Stock 1.3K $187.53 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction made pursuant to Mr. Altshuler's company approved trading plan under Rule 10b5-1.
F2 Mr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
F3 Open market sales reported on this line occurred at a weighted average price of $290.32 (range $290.05 to $290.64).
F4 Open market sales reported on this line occurred at a weighted average price of $291.53 (range $291.06 to $291.91).
F5 Open market sales reported on this line occurred at a weighted average price of $293.02 (range $292.41 to $293.36).
F6 Open market sales reported on this line occurred at a weighted average price of $293.99 (range $293.58 to $294.26).
F7 Open market sales reported on this line occurred at a weighted average price of $295.14 (range $294.74 to $295.53).
F8 The option vests in 16 quarterly installments from 2/6/2019.